Researchers at London Health Sciences Centre Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to treat renal cell carcinoma (kidney cancer) by inserting microscopic beads filled with radiation directly into blood vessels surrounding cancerous tumours. The goal is to improve patient outcomes through a new treatment option.

What if the presence of a well-known but misunderstood viral protein explains why some people living with HIV (PLWH) never recover their health, even with antiretroviral treatment?

Dr. Madeleine Durand and Andrés Finzi, researchers at the CRCHUM, Université de Montréal’s affiliated hospital research centre, will explore this through the launch of a groundbreaking clinical trial this fall.

Three graduate students in CSHL’s dos Santos lab have developed a tool called MaGNet to quickly measure changes in mouse mammary glands. This open-source technology can be used to study how hormonal changes affect mammary glands and may one day allow for earlier breast cancer diagnoses.

• Most patients receiving chemotherapy with taxanes or platinum salts develop painful neuropathy in hands and feet, often forcing dose reduction or treatment interruption.

• Published in Clinical and Translational Oncology, the study demonstrates that topical application of Oncapsisens® delays and reduces neuropathic symptoms, paving the way for new preventive options for cancer patients.